Literature DB >> 11916331

Molecular and cytogenetic analyses on Brazilian youths with pervasive developmental disorders.

MarcosRobertoHigino Estécio1, Agnes Cristina Fett-Conte, Marileila Varella-Garcia, Cíntia Fridman, Ana Elizabete Silva.   

Abstract

The Pervasive Developmental Disorders (PDDs) constitute a group of behavioral and neurobiological impairment conditions whose main features are delayed communicative and cognitive development. Genetic factors are reportedly associated with PDDs and particular genetic abnormalities are frequently found in specific diagnostic subgroups such as the autism spectrum disorders. This study evaluated cytogenetic and molecular parameters in 30 youths with autism or other PDDs. The fragile X syndrome was the most common genetic abnormality detected, presented by 1 patient with autism and 1 patient with PPD not-otherwise specified (PPD-NOS). One girl with PDD-NOS was found to have tetrasomy for the 15q11-q13 region, and one patient with autism exhibited in 2/100 metaphases an inv(7)(p35q36), thus suggesting a mosaicism 46,XX/46,XX,inv(7)(p15q36) or representing a coincidental finding. The high frequency of chromosomopathies support the hypothesis that PDDs may develop as a consequence to chromosomal abnormalities and justify the cytogenetic and molecular assessment in all patients with PDDs for establishment of diagnosis.

Entities:  

Mesh:

Year:  2002        PMID: 11916331     DOI: 10.1023/a:1017952123258

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  38 in total

1.  A case of infantile autism associated with Down's syndrome.

Authors:  S Wakabayashi
Journal:  J Autism Dev Disord       Date:  1979-03

2.  Autism associated with marker chromosome.

Authors:  C Gillberg; S Steffenburg; J Wahlström; I C Gillberg; A Sjöstedt; T Martinsson; S Liedgren; O Eeg-Olofsson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1991-05       Impact factor: 8.829

3.  Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain.

Authors:  M Abitbol; C Menini; A L Delezoide; T Rhyner; M Vekemans; J Mallet
Journal:  Nat Genet       Date:  1993-06       Impact factor: 38.330

4.  Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study.

Authors:  A Philippe; M Martinez; M Guilloud-Bataille; C Gillberg; M Råstam; E Sponheim; M Coleman; M Zappella; H Aschauer; L Van Maldergem; C Penet; J Feingold; A Brice; M Leboyer; L van Malldergerme
Journal:  Hum Mol Genet       Date:  1999-05       Impact factor: 6.150

Review 5.  Etiology of autism: genetic influences.

Authors:  S E Folstein; J Piven
Journal:  Pediatrics       Date:  1991-05       Impact factor: 7.124

6.  Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei.

Authors:  P M Rodier; J L Ingram; B Tisdale; S Nelson; J Romano
Journal:  J Comp Neurol       Date:  1996-06-24       Impact factor: 3.215

7.  Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome.

Authors:  H L Hinds; C T Ashley; J S Sutcliffe; D L Nelson; S T Warren; D E Housman; M Schalling
Journal:  Nat Genet       Date:  1993-01       Impact factor: 38.330

8.  A PCR-based test suitable for screening for fragile X syndrome among mentally retarded males.

Authors:  L A Haddad; R C Mingroni-Netto; A M Vianna-Morgante; S D Pena
Journal:  Hum Genet       Date:  1996-06       Impact factor: 4.132

Review 9.  Schizophrenia, sensory gating, and nicotinic receptors.

Authors:  L E Adler; A Olincy; M Waldo; J G Harris; J Griffith; K Stevens; K Flach; H Nagamoto; P Bickford; S Leonard; R Freedman
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

10.  Rescue of the En-1 mutant phenotype by replacement of En-1 with En-2.

Authors:  M Hanks; W Wurst; L Anson-Cartwright; A B Auerbach; A L Joyner
Journal:  Science       Date:  1995-08-04       Impact factor: 47.728

View more
  8 in total

1.  Identification of expanded alleles of the FMR1 gene among high-risk population in Indonesia by using blood spot screening.

Authors:  Tri Indah Winarni; Agustini Utari; Farmaditya E P Mundhofir; Tzuhan Tong; Blythe Durbin-Johnson; Sultana M H Faradz; Flora Tassone
Journal:  Genet Test Mol Biomarkers       Date:  2011-10-11

2.  Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder.

Authors:  Catalina García-Nonell; Eugenia Rigau Ratera; Susan Harris; David Hessl; Michele Y Ono; Nicole Tartaglia; Emily Marvin; Flora Tassone; Randi J Hagerman
Journal:  Am J Med Genet A       Date:  2008-08-01       Impact factor: 2.802

3.  Autism profiles of males with fragile X syndrome.

Authors:  Susan W Harris; David Hessl; Beth Goodlin-Jones; Jessica Ferranti; Susan Bacalman; Ingrid Barbato; Flora Tassone; Paul J Hagerman; Herman Herman; Randi J Hagerman
Journal:  Am J Ment Retard       Date:  2008-11

4.  Plasma cytokine profiles in Fragile X subjects: is there a role for cytokines in the pathogenesis?

Authors:  Paul Ashwood; Danh V Nguyen; David Hessl; Randi J Hagerman; Flora Tassone
Journal:  Brain Behav Immun       Date:  2010-01-25       Impact factor: 7.217

5.  Brief report: Sensorimotor gating in idiopathic autism and autism associated with fragile X syndrome.

Authors:  Jennifer Yuhas; Lisa Cordeiro; Flora Tassone; Elizabeth Ballinger; Andrea Schneider; James M Long; Edward M Ornitz; David Hessl
Journal:  J Autism Dev Disord       Date:  2011-02

6.  Cytogenetic abnormalities and fragile-X syndrome in Autism Spectrum Disorder.

Authors:  Kavita S Reddy
Journal:  BMC Med Genet       Date:  2005-01-18       Impact factor: 2.103

7.  Model-based evaluation of the impact of formulation and food intake on the complex oral absorption of mavoglurant in healthy subjects.

Authors:  Thierry Wendling; Kayode Ogungbenro; Etienne Pigeolet; Swati Dumitras; Ralph Woessner; Leon Aarons
Journal:  Pharm Res       Date:  2014-11-26       Impact factor: 4.200

8.  The genetic overlap of attention deficit hyperactivity disorder and autistic spectrum disorder.

Authors:  Arie J Stam; Patricia F Schothorst; Jacob As Vorstman; Wouter G Staal
Journal:  Appl Clin Genet       Date:  2009-03-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.